Catalyst Wire Dossier Catalyst Wire Dossier

NiCord/CordIn (omidubicel)

omidubicel · Gamida Cell Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NiCord/CordIn (omidubicel), covering 2024-10-23 to 2024-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

See pricing